Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.08.23
/
50%
€15.80
Target price
07.08.24
€15.45
Performance (%)
32.91%
Price
05.06.24
€20.40
Summary
This prediction is currently active. The SELL prediction by JPMorgan_Chase___Co_ for Myriad Genetics is trending in the completely wrong direction and now has a performance of 32.91%. This prediction currently runs until 07.08.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | -2.857% | -2.857% |
iShares Core DAX® | 0.597% | 3.083% |
iShares Nasdaq 100 | 0.899% | 5.338% |
iShares Nikkei 225® | 1.775% | -1.206% |
iShares S&P 500 | 0.990% | 3.500% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $18.00 to $17.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat